NOBLE COLD-ADAPTED ATTENUATED MERS-COV

PLASMID DNA PURIFICATION METHODS

CRISPR-BASED PROGRAMMABLE RNA EDITING

Immunogenic Constructs And Vaccines For Use In The Prophylactic And Therapeutic Treatment Of Diseases Caused By SARS-CoV-2

SARS-COV-2 POLYPEPTIDES AND USES THEREOF

ANTIGEN DELIVERY PLATFORM AND METHODS OF USE

FUSION PROTEINS COMPRISING SARS-COV-2 SPIKE PROTEIN OR THE RECEPTOR THEREOF

A VACCINE FOR CORONAVIRUS AND INFLUENZA VIRUS, AND METHOD FOR PREPARATION THEREOF

UTILIZATION OF ANTIBODIES TO SHAPE ANTIBODY RESPONSES TO AN ANTIGEN

Peptide VLP-Based Vaccines

NOVEL CORONAVIRUS SARS-CoV-2 SAFE REPLICON SYSTEM AND USE THEREOF

FOLD PROMOTERS AND THEIR USE FOR THE PRODUCTION AND STABILIZATION OF POLYPEPTIDES

VACCINE COMPOSITION COMPRISING A LEISHMANIA HOST CELL EXPRESSING AT LEAST ONE PROTEIN OF THE FAMILY CORONAVIRIDAE

FULLY SYNTHETIC, LONG-CHAIN NUCLEIC ACID FOR VACCINE PRODUCTION TO PROTECT AGAINST CORONAVIRUSES

STEM CELL COMPOSITIONS FOR CULTURING CORONAVIRUSES AND METHODS OF MAKING AND USING THEREOF

COVID-19 VACCINE BASED ON THE MYXOMA VIRUS PLATFORM

CORONA NUCLEOCAPSID ANTIGEN FOR USE IN ANTIBODY-IMMUNOASSAYS

CRISPR-based programmable RNA editing

UNIVERSAL BACTERIOPHAGE T4 NANOPARTICLE PLATFORM TO DESIGN MULTIPLEX SARS-COV-2 VACCINE CANDIDATES BY CRISPR ENGINEERING

Bovine rotavirus fusion protein and calf diarrhea multivalent vaccine

CORONA NUCLEOCAPSID ANTIGEN FOR USE IN ANTIBODY-IMMUNOASSAYS

ORAL VACCINES EXPRESSED IN YEAST FOR COVID-19

Mutant spike protein extending the tissue tropism of infectious bronchitis virus (IBV)

Cell line for producing coronaviruses

Feline cell capable of being cultured without animal-derived protein, and method for producing virus and method for producing vaccine using thereof